Treatment and outcome of adult patients with acute asthma in emergency departments in Australasia, South East Asia and Europe: Are guidelines followed? AANZDEM/EuroDEM study.


Journal

Emergency medicine Australasia : EMA
ISSN: 1742-6723
Titre abrégé: Emerg Med Australas
Pays: Australia
ID NLM: 101199824

Informations de publication

Date de publication:
10 2019
Historique:
received: 06 11 2018
revised: 08 01 2019
accepted: 09 01 2019
pubmed: 26 2 2019
medline: 9 6 2020
entrez: 27 2 2019
Statut: ppublish

Résumé

Asthma exacerbations are common presentations to ED. Key guideline recommendations for management include administration of inhaled bronchodilators, systemic corticosteroids and titrated oxygen therapy. Our aim was to compare management and outcomes between patients treated for asthma in Europe (EUR) and South East Asia/Australasia (SEA) and compliance with international guidelines. In each region, prospective, interrupted time series studies were performed including adult (age >18 years) patients presenting to ED with the main complaint of dyspnoea during three 72 h periods. This was a planned sub-study that included those with an ED primary diagnosis of asthma. Data was collected on demographics, clinical features, treatment in ED, diagnosis, disposition and in-hospital outcome. The results of interest were differences in treatment and outcome between EUR and SEA cohorts. Five hundred and eighty-four patients were identified from 112 EDs (66 EUR and 46 SEA). The cohorts had similar demographics and co-morbidity patterns, with 89% of the cohort having a previous diagnosis of asthma. There were no significant differences in treatment between EUR and SEA patients - inhaled beta-agonists were administered in 86% of cases, systemic corticosteroids in 66%, oxygen therapy in 44% and antibiotics in 20%. Two thirds of patients were discharged home from the ED. The data suggests that compliance with guideline-recommended therapy in both regions, particularly corticosteroid administration, is sub-optimal. It also suggests over-use of antibiotics.

Identifiants

pubmed: 30806041
doi: 10.1111/1742-6723.13242
doi:

Substances chimiques

Bronchodilator Agents 0

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

756-762

Subventions

Organisme : Department of Health
ID : PDF-2012-05-193
Pays : United Kingdom
Organisme : Research Council of Lithuania
ID : MIP-049/2015
Pays : International
Organisme : Queensland Emergency Medicine Research Foundation
ID : EMPJ-108R21-2014
Pays : International

Informations de copyright

© 2019 Australasian College for Emergency Medicine.

Références

Prekker ME, Feemster LC, Hough CL et al. The epidemiology and outcome of prehospital respiratory distress. Acad. Emerg. Med. 2014; 21: 543-50.
Kelly AM, Keijzers G, Klim S et al. An observational study of dyspnea in emergency departments: the Asia, Australia, and New Zealand dyspnea in emergency departments study (AANZDEM). Acad. Emerg. Med. 2017; 24: 328-36.
British guideline on the management of asthma. Thorax 2014; 69: 1-192.
National Asthma Council Australia. Australian Asthma Handbook, Version 1.2. National Asthma Council Australia, Melbourne, 2016. [Cited Jul 2018.] Available from URL: http://www.asthmahandbook.org.au
National Asthma Education and Prevention Program. Third Expert Panel on the Diagnosis and Management of Asthma. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 2007.
Global Strategy for Asthma Management and Prevention GINA (Global Initative for Asthma) Report, 2016. [Cited Sep 2016.] Available from URL: http://www.ginasthma.org
Vezina K, Chauhan BF, Ducharme FM. Inhaled anticholinergics and short-acting beta(2)-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital. Cochrane Database Syst. Rev. 2014: CD010283.
Kew KM, Kirtchuk L, Michell CI. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department. Cochrane Database Syst. Rev. 2014: CD010909.
Nair P, Milan SJ, Rowe BH. Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma. Cochrane Database Syst. Rev. 2012: CD002742.
Travers AH, Milan SJ, Jones AP, Camargo CA Jr, Rowe BH. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma. Cochrane Database Syst. Rev. 2012: CD010179.
Goyal S, Agrawal A. Ketamine in status asthmaticus: a review. Indian J. Crit. Care Med. 2013; 17: 154-61.
Pallin M, Naughton MT. Noninvasive ventilation in acute asthma. J. Crit. Care 2014; 29: 586-93.
Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst. Rev. 2001: CD002178.
Johnston SL, Pattemore PK, Sanderson G et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am. J. Respir. Crit. Care Med. 1996; 154: 654-60.
Vanderweil SG, Tsai CL, Pelletier AJ et al. Inappropriate use of antibiotics for acute asthma in United States emergency departments. Acad. Emerg. Med. 2008; 15: 736-43.
Hijazi Z, Abdulmalek AK, Al-Taweel F, Al-Shareda S. Hospital management of children with acute asthma exacerbations in Kuwait: adherence to international guidelines. Med. Princ. Pract. 2002; 11: 126-30.
Johnston SL, Szigeti M, Cross M et al. Azithromycin for acute exacerbations of asthma: The AZALEA randomized clinical trial. JAMA Int. Med. 2016; 176: 1630-7.
Brusselle GG, Van Braeckel E. AZALEA trial highlights antibiotic overuse in acute asthma attacks. JAMA Int. Med. 2016; 176: 1637-8.
Hasegawa K, Chiba T, Hagiwara Y et al. Quality of care for acute asthma in emergency departments in Japan: a multicenter observational study. J. Allergy Clin. Immunol. Pract. 2013; 1: 509.
Hasegawa K, Sullivan AF, Tsugawa Y et al. Comparison of US emergency department acute asthma care quality: 1997-2001 and 2011-2012. J. Allergy Clin. Immunol. 2015; 135: 73-80.
Dexheimer JW, Abramo TJ, Arnold DH et al. Implementation and evaluation of an integrated computerized asthma management system in a pediatric emergency department: a randomized clinical trial. Int. J. Med. Inform. 2014; 83: 805-13.
Self TH, Usery JB, Howard-Thompson AM, Sands C. Asthma treatment protocols in the emergency department: are they effective? J. Asthma 2007; 44: 243-8.
Bekmezian A, Fee C, Weber E. Clinical pathway improves pediatrics asthma management in the emergency department and reduces admissions. J. Asthma 2015; 52: 806-14.
Telreja N, Soubani AO, Sherwin RL, Baptist AP. Modifiable factors associated with severe asthma exacerbations in urban patients. Ann. Allergy Asthma Immunol. 2012; 109: 128-32.

Auteurs

Simon Craig (S)

Emergency Department, Monash Medical Centre, Melbourne, Victoria, Australia.
School of Clinical Sciences, Monash Health, Monash University, Melbourne, Victoria, Australia.

Win Sen Kuan (WS)

Emergency Medicine Department, National University Health System, Singapore.
Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Anne-Maree Kelly (AM)

Joseph Epstein Centre for Emergency Medicine Research, Western Health, Melbourne, Victoria, Australia.
Department of Medicine, Melbourne Medical School - Western Precinct, The University of Melbourne, Melbourne, Victoria, Australia.

Oene Van Meer (O)

Leiden University Medical Center, Leiden, The Netherlands.

Justina Motiejunaite (J)

INSERM, U942, BIOmarkers in CArdioNeuroVAScular diseases, Paris, France.
Department of Anesthesiology and Critical Care, APHP, Saint Louis Lariboisière Hospitals, Paris, France.
Department of Cardiology, Lithuanian University of Health Sciences Kaunas Clinics, Kaunas, Lithuania.

Gerben Keijzers (G)

Department of Emergency Medicine, Gold Coast University Hospital, Brisbane, Queensland, Australia.
Faculty of Health Sciences and Medicine, Bond University, Brisbane, Queensland, Australia.
School of Medicine, Griffith University, Brisbane, Queensland, Australia.

Peter Jones (P)

Emergency Department, Auckland City Hospital, Auckland, New Zealand.
Department of Surgery, The University of Auckland, Auckland, New Zealand.

Richard Body (R)

Emergency Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Division of Cardiovascular Sciences, The University of Manchester, Manchester, UK.

Mehmet A Karamercan (MA)

Emergency Medicine Department, Faculty of Medicine, Gazi University, Ankara, Turkey.
Department of Emergency Medicine, Istanbul Bagcilar Training and Research Hospital, Istanbul, Turkey.

Sharon Klim (S)

Joseph Epstein Centre for Emergency Medicine Research, Western Health, Melbourne, Victoria, Australia.

Veli-Pekka Harjola (VP)

Emergency Medicine, University of Helsinki, Helsinki, Finland.
Department of Emergency Medicine and Services, Helsinki University Hospital, Helsinki, Finland.

Franck Verschuren (F)

Department of Acute Medicine, Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Anna Holdgate (A)

Department of Emergency Medicine, Liverpool Hospital, Sydney, New South Wales, Australia.
Southwest Clinical School, The University of New South Wales, Sydney, New South Wales, Australia.

Michael Christ (M)

Emergency Department, Luzerner Kantonsspital, Luzern, Switzerland.

Adela Golea (A)

Emergency Medicine, County Emergency Hospital Cluj-Napoca, University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Colin A Graham (CA)

Emergency Medicine, Chinese University of Hong Kong, Hong Kong.

Jean Capsec (J)

Public Health Department, Tours University Hospital, Tours, France.

Cinzia Barletta (C)

Department of Emergency Medicine, Santa Eugenio Hospital, Rome, Italy.

Luis Garcia-Castrillo (L)

Servicio Urgencias Hospital Marqués de Valdecilla, Santander, Spain.

Said Laribi (S)

School of Medicine, INSERM U1100, Tours University, Tours, France.
Emergency Medicine Department, Tours University Hospital, Tours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH